期刊文献+

《浙江医学》对作者署名的一般要求

下载PDF
导出
摘要 同时具备以下3项条件者方可署名为作者:(1)参与选题和设计或资料的分析与解释者;(2)起草或修改论文中关键性理论或其他主要内容者;(3)能对编辑部的修改意见进行核修。在学术界进行答辩,并最终同意该文发表者。仅参与研究项目资金的获得或收集资料者不能列为作者,仅对科研小组进行一般管理者也不宜列为作者。对文章中的各主要结论,均必须至少有1位作者负责。作者中如有外籍作者。
出处 《浙江医学》 CAS 2012年第20期1653-1653,共1页 Zhejiang Medical Journal
  • 相关文献

参考文献11

  • 1江昌新,谭郁彬.内分泌器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:154-186.
  • 2Miettinen M, Fetsch J F.Distributon of Keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis[J]. Hum pathol,2000,31 ( 9 ):1062-1067.
  • 3Erkilie S, Kocer N E. The of cytokeratin 19 in the differential diagnosis of true papillary Carcinoma of thyroid and papillary carcinoma-like changes in graves' disease[J].Endoer pathol,2005,16 ( 1 ):63-66.
  • 4Lam K Y. Lui M C, Lo C Y. Cytokeratin expression profiles in thyroid carcinomas[J].Eur J Surg 0ncol,2001,27( 7 }: 631-635.
  • 5Beesley M F, McLaren K M. Cytokeratin 19 and galectin-3 immunohstochemistry in the differential diagnosis of solitary thyroid noduies[J].Histopathology,2002,41 ( 3 ): 236-243.
  • 6Coli A, Bgotti G, Zuccbetti F, et al. Galectin-3, amarker of Well-differentiated thvroid carcinoma is expressed in thyroid nodules with cytological atypia[J]. Histopathotogy, 2002, 40(1): 80-87.
  • 7Miettinon M, Karkkainen P. Differential reactivity of HBME1 and CD15 antibodies in benign ang malignant thyroid tumors preferentical reactivity with malignant tumors[J]. Virchows Arch, 1996, 429( 4-5 ):213-219.
  • 8项灿宏,李启东,姚力,王文跃,赵恭华.周期素D1和p27在甲状腺腺瘤及乳头状癌中的表达及其意义[J].中日友好医院学报,2007,21(3):156-158. 被引量:4
  • 9Khoo M L,Beasler N J,Ezzat S,et aI.Overexpression of cyclinD1 and underexpression of p27 prediet lymph node metastases in papillary thyyoid carcinoma [J]. J Clin Endoerinol Metab, 2002, 87 (4):1814-1818.
  • 10Savin S,Cvejic D,Isic T.et aI.Thyroid peroxidase immunohisto- chemistry in differential diagnosis of thyroid tumors [J]. Endocr pathol,2006,17(1):53-60.

二级参考文献6

  • 1Wang S,Wuu J,Savas L,et al.The role of cell cycle regulatory proteins,cyclin D1,cyclin E,and p27 in thyroid carcinogenesis[J].Hum Pathol.1998,29:1304-1309.
  • 2Saltman B,Singh B,Hedvat CV,et al.Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression[J].Surgery,2006,140(6):899-905.
  • 3Khoo ML,Beasley NJ,Ezzat S,et al.Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma[J].J Clin Endocrinol Metab,2002,87(4):1814-1818.
  • 4Hartwell LH,Kastan MB.Cell cycle control and cancer[J].Science,1994,266:1821-1828.
  • 5Toyoshima H,Hunter T:p27,a novel inhibitor of G1 cyclin/cdk activity,is related to p21[J].Cell,1994,78:67-74.
  • 6郭贵龙,姚榛祥.p27及Ki-67对鉴别良、恶性甲状腺滤泡状肿瘤的价值[J].中国普通外科杂志,2002,11(5):289-292. 被引量:16

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部